We may earn if you use our links. details
FORECASTEDNationwide

RNomics Technology Enhancement Centers

The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies an

Plain-language brief

What this opportunity funds

The NIH Common Fund, in partnership with other NIH Institutes and Centers, plans to issue Notices of Funding Opportunity (NOFOs) for the RNomics program, which seeks to develop tools for studying the full set of RNA molecules (the RNome) in cells and tissues. The program will support technologies and resources that enable integrated analysis of RNA sequences, modifications, structures, locations, interactions, and functions to advance understanding of health and disease. RNomics includes four initiatives: technology enhancement centers, transformative technologies, molecular standards, and a coordinating center. Applications are not being solicited at this time. This notice is being provided to give potential applicants time to develop meaningful collaborations and strong projects. This NOFO will establish collaborative RNomics Technology Enhancement Centers (RTECs). RTECs will further develop existing technologies with demonstrated feasibility. These centers will strengthen experimental and computational tools for measuring, mapping, and testing RNA in cells and tissues, with the goal of delivering measurable improvements and supporting broad community use. Priority areas include end-to-end RNA sequencing and quantitative modification mapping; comprehensive analysis of RNA sequence, structure, modification, interactions, localization, dynamics, and function; and molecular and biochemical tools for RNA manipulation, processing, and functional testing.

Eligibility at a glance

Eligible applicants
Others (see text field entitled "Additional Information on Eligibility" for clarification), Public housing authorities/Indian housing authorities, Special district governments, County governments, Small businesses, For profit organizations other than small businesses, Public and State controlled institutions of higher education, State governments, Independent school districts, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, City or township governments, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Native American tribal governments (Federally recognized)
Eligible locations
Eligible applicants across the United States
Eligible activities
Health
Matching requirement
Not specified
Registration
SAM.gov, Grants.gov

Application process

  1. Read the complete official notice and confirm every eligibility rule.
  2. Complete required registrations early; federal registrations can take time.
  3. Build the budget, work plan, evidence, and attachments requested by the sponsor.
  4. Submit through the official portal and retain the confirmation.

Change history

No material changes have been recorded since this opportunity entered the hub.

Related opportunities

FORECASTEDNationwide

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics

National Institutes of Health

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), as part of its stewardship of Congressionally-mandated activities under the Best Pharmaceuticals for Children Act (BPCA) and implementation of recommendations of the Task Force on Research Specific to Pregna

Award
Amount not specified
Deadline
Not specified
Intermediary grantFor profit organizations other than small businessesIntermediary / support
source verifiedVerified Aug 21, 2026
FORECASTEDNationwide

Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)

National Institutes of Health

Type 1 diabetes (T1D) is a complex disease involving interactions among many different cell types, tissues, organs and biological processes. Genetics, the environment, and lifestyle all play a role in disease development and progression. Over the past two decades, the National Institute of Diabetes

Award
Amount not specified
Deadline
Not specified
Intermediary grantIndependent school districtsIntermediary / support
source verifiedVerified Aug 21, 2026
FORECASTEDNationwide

Partnership with Common Fund Data Ecosystem Resources

National Institutes of Health

The NIH Office of Strategic Coordination (Common Fund) has generated many valuable and widely available datasets. The Common Fund Data Ecosystem is helping to ensure that all Common Fund (CF) data are Findable, Accessible, Interoperable, and Reusable (FAIR). The purpose of this Notice of Funding Opp

Award
Up to $1,200,000
Deadline
Not specified
Intermediary grantCity or township governmentsIntermediary / support
source verifiedVerified Aug 7, 2026